Federated Hermes’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
Federated Hermes's GYRE Position: Q3 2026 in Review
Federated Hermes opened a new position in Gyre Therapeutics (GYRE) in Q3 2026: 1,648 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: Federated Hermes previously reported a position in GYRE as recently as Q3 2018.
Federated Hermes first reported a position in GYRE in Q3 2018 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.
- Federated Hermes held 1,648 shares of Gyre Therapeutics worth $12.1K as of Q3 2026.
- Gyre Therapeutics was a new Federated Hermes position in Q3 2026.
- Gyre Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1809 holding.
- Federated Hermes first reported a position in Gyre Therapeutics in Q3 2018 and has held it in 2 quarters since.
- 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.
Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.